External Cephalic Version (ECV) for Twins With Non-vertex Presenting Twin

Twin Pregnancy With Antenatal Problem Clinical Trial

Official title:

External Cephalic Version (ECV) for Twins With Non-vertex Presenting Twin

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05894785
• Other study ID #: 0327-21-SZMC
• Status: Recruiting
• Phase: N/A
• Start date: February 27, 2022
• Est. completion date: December 30, 2025

Study information

• Verified date: April 2024
• Source: Shaare Zedek Medical Center
• Contact: Zvi Ehrlich
• Phone: +9726555562
• Email: ehrlichz[@]szmc.org.il
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

In this study, women with a twin pregnancy with the presenting twin in a non-vertex(head) presenting twin undergo an external cephalic version.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 30
• Est. completion date: December 30, 2025
• Est. primary completion date: December 1, 2025
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• 18 years old or older multiparous no previous cesarean delivery (CD) a non-vertex presenting twin in a term (37 weeks gestation and onwards) dichorionic diamniotic twin pregnancy

Exclusion Criteria:

• contraindication for a vaginal delivery nulliparous monochorionic diamniotic pregnancy

Related Conditions & MeSH terms

• Twin Pregnancy With Antenatal Problem

Intervention

Procedure:
• External cephalic version
An ECV attempt is made on the study group

Locations

Country	Name	City	State
Israel	Shaare Zedek Medical Center	Jerusalem

Sponsors (1)

Lead Sponsor	Collaborator
Shaare Zedek Medical Center

Country where clinical trial is conducted

Israel, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Success rates of ECV		1 day
Secondary	Maternal and fetal morbidities		up to 7 days from enrollment